Special focus on challenges and opportunities for the development and use of vaccines in Africa-Reference-Cited by-同舟云学术

Special focus on challenges and opportunities for the development and use of vaccines in Africa

Published:2018-09-27 Issue:10 Volume:14 Page:2335-2339
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Madhi Shabir A.¹²³^ORCID,Rees Helen³⁴

Affiliation:

1. Faculty of Health Science, Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa

2. Faculty of Health Science, Department of Science/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa

3. Faculty of Health Science, African Leadership in Vaccinology Expertise, University of the Witwatersrand, Johannesburg, South Africa

4. Faculty of Health Science, Wits Reproductive Health Institute, University of the Witwatersrand, Johannesburg, South Africa

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2018.1522921

Reference23 articles.

1. Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa

2. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15

3. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps